Pioneering Pain-free Solutions
We leverage the power of medical technology to develop transformative, accurate solutions that improve the quality of life.
We are on a mission to redefine the approach to testing and deliver pain-free, accessible solutions that drive transformative change and improve the quality of life.
Our Technology
Revolutionizing Drug Testing Through Fingerprint Sweat Analysis
Our innovative Intelligent Fingerprinting Drug Testing Solution detects commonly abused drugs via sweat from the fingertips. The system’s ease of use and portability make it a convenient solution for reliable drug screening and identification of potential misuse within the 16-24 hours before testing.
Fingerprint DRUG Testing
A Dignified Approach to Drug Testing
Our Intelligent Fingerprinting Drug Screening System tests fingertip sweat for recent drug use, including cannabis, cocaine, opiates, and methamphetamine. Samples are collected in less than one minute and results displayed in less than ten minutes.
Non-invasive Drug Monitoring
SmarTest® Sweat Drug Testing Patch
The SmarTest Patch is a discreet, wearable device that detects drug use through sweat over a 7 to 10-day period. Comfortable, tamper-evident, and water-resistant, it’s ideal for longer-term monitoring in justice and rehabilitation settings.
Used alongside our Intelligent Fingerprinting Drug Screening System, it offers a complete non-invasive sweat-based solution for both immediate and continuous drug detection.
INVESTOR RELATIONS
Transforming Testing Solutions Through Med Tech Innovation
Intelligent Bio Solutions (NASDAQ: INBS) is a medical technology company delivering intelligent, rapid, non-invasive testing solutions. Its Intelligent Fingerprinting Drug Testing Solution is currently being sold into 35 countries and territories, with more than 480 active customer accounts. INBS is working toward FDA clearance and U.S. market entry, positioned to capitalize on the rapidly growing, multi-billion-dollar U.S. drug screening market
Intelligent Bio Solutions News
Intelligent Bio Solutions Reports Fiscal Third Quarter Revenue Growth of 46% Year-over-Year
NEW YORK, May 13, 2026 – Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced its financial results and operational highlights for the fiscal third quarter and nine months ended March 31, 2026, and provided a business update. “The third quarter marked…
Intelligent Bio Solutions Initiates Validation Study for Rapid Drug Screening Cartridge Targeting 70% Faster Results
NEW YORK, April 20, 2026 – Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the launch of a validation study aimed at significantly reducing the analysis time of its Intelligent Fingerprinting Drug Screening System. The study aims to improve the already…
Intelligent Bio Solutions Advances Upcoming FDA 510(k) Submission, Successfully Completes Penetration Testing with No Major Vulnerabilities Identified
NEW YORK, April 17, 2026 – Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the successful completion of penetration testing as part of its upcoming FDA 510(k) submission. The testing identified no major vulnerabilities, verified the robustness of the Company’s existing security…